Opinion | Annual Check-Up: Mark Cuban’s Cost Plus Drugs
On February 16, 2022, medical student Jared Dashevsky shared his perspective on Mark Cuban’s new business endeavor, the Cost Plus Drug Company. As part of MedPage Today‘s review of the past year’s top events, Dashevsky follows up with his thoughts on how the company is doing nearly 1 year post-launch and where it may be […]